Palantir PLTR Stock Analysis #shorts

Youth-onset diabetes linked to higher Alzheimer’s risk

Young people with diabetes may have a significantly higher risk of developing Alzheimer’s disease later in life, according to a new study by researchers in

May 9, 2024

Signal: Roche to refile subcutaneous Tecentriq with FDA after UK approval – Pharmaceutical Technology

Roche has pushed back the launch of its subcutaneous Tecentriq to 2024. Photo: Qilai Shen/Bloomberg via Getty Images. Pharmaceuticals giant Roche reportedly plans to file

September 13, 2023

BioNTech partners with Autolus to advance CAR-T therapies

Share this article BioNTech intends to commence ten registrational clinical trials, including the BNT211 programme by the end of 2024. Credit: dayandnightcollective / Shutterstock.com. BioNTech

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.